AnaptysBio, Inc.
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- AnaptysBio, Inc.
- Company name
- AnaptysBio, Inc.
- Organisation type
- Industry
- Registered legal name
- ANAPTYSBIO, INC.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0001370053
- Legal Entity Identifier (LEI)
- 529900HH4WQT03IG1A12
Related records
Trials (9)
- A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)
- A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)
- A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata
- Analysis of Peripheral Blood ILC2s and Th2 Cells in Response to ANB020
- Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
- Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma
- Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy
- This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).